Matthew T. Geballe, Ph.D. - Publications

Chemistry Emory University, Atlanta, GA 
Medicinal, Bioorganic, Synthetic Organic, Computational

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Burger PB, Yuan H, Karakas E, Geballe M, Furukawa H, Liotta DC, Snyder JP, Traynelis SF. Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators. Molecular Pharmacology. 82: 344-59. PMID 22596351 DOI: 10.1124/Mol.112.078568  0.44
2010 Dravid SM, Burger PB, Prakash A, Geballe MT, Yadav R, Le P, Vellano K, Snyder JP, Traynelis SF. Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2741-54. PMID 20164358 DOI: 10.1523/Jneurosci.5390-09.2010  0.44
2010 Prussia AJ, Yang Y, Geballe MT, Snyder JP. Cyclostreptin and microtubules: Is a low-affinity binding site required? Chembiochem. 11: 101-109. PMID 19946930 DOI: 10.1002/Cbic.200900538  0.6
2009 Yuan H, Vance KM, Junge CE, Geballe MT, Snyder JP, Hepler JR, Yepes M, Low CM, Traynelis SF. The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors. The Journal of Biological Chemistry. 284: 12862-73. PMID 19240037 DOI: 10.1074/Jbc.M805123200  0.44
2008 Ng FM, Geballe MT, Snyder JP, Traynelis SF, Low CM. Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. Molecular Brain. 1: 16. PMID 19017396 DOI: 10.1186/1756-6606-1-16  0.44
2008 Tahirovic YA, Geballe M, Gruszecka-Kowalik E, Myers SJ, Lyuboslavsky P, Le P, French A, Irier H, Choi WB, Easterling K, Yuan H, Wilson LJ, Kotloski R, McNamara JO, Dingledine R, et al. Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists. Journal of Medicinal Chemistry. 51: 5506-21. PMID 18800760 DOI: 10.1021/Jm8002153  0.44
2008 Chen PE, Geballe MT, Katz E, Erreger K, Livesey MR, O'Toole KK, Le P, Lee CJ, Snyder JP, Traynelis SF, Wyllie DJ. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. The Journal of Physiology. 586: 227-45. PMID 17962328 DOI: 10.1113/Jphysiol.2007.143172  0.44
2008 Yuan H, Geballe MT, Hansen KB, Traynelis SF. Structure and function of the NMDA receptor Structural and Functional Organization of the Synapse. 289-316. DOI: 10.1007/978-0-387-77232-5_11  0.44
2007 Shanker N, Kingston DG, Ganesh T, Yang C, Alcaraz AA, Geballe MT, Banerjee A, McGee D, Snyder JP, Bane S. Enhanced microtubule binding and tubulin assembly properties of conformationally constrained paclitaxel derivatives. Biochemistry. 46: 11514-27. PMID 17892304 DOI: 10.1021/Bi700753Y  0.44
2007 Ng FM, Soh W, Geballe MT, Low CM. Improving solubility of NR2B amino-terminal domain of N-methyl-d-aspartate receptor expressed in Escherichia coli. Biochemical and Biophysical Research Communications. 362: 69-74. PMID 17706601 DOI: 10.1016/J.Bbrc.2007.07.164  0.44
2007 Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jørgensen L, Clausen RP, Wyllie DJ, Snyder JP, Traynelis SF. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Molecular Pharmacology. 72: 907-20. PMID 17622578 DOI: 10.1124/Mol.107.037333  0.44
2006 Kristensen AS, Geballe MT, Snyder JP, Traynelis SF. Glutamate receptors: variation in structure-function coupling. Trends in Pharmacological Sciences. 27: 65-9. PMID 16406088 DOI: 10.1016/J.Tips.2005.12.005  0.44
2005 Erreger K, Geballe MT, Dravid SM, Snyder JP, Wyllie DJ, Traynelis SF. Mechanism of partial agonism at NMDA receptors for a conformationally restricted glutamate analog. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7858-66. PMID 16120788 DOI: 10.1523/Jneurosci.1613-05.2005  0.44
2005 Holm MM, Naur P, Vestergaard B, Geballe MT, Gajhede M, Kastrup JS, Traynelis SF, Egebjerg J. A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study. The Journal of Biological Chemistry. 280: 35469-76. PMID 16103115 DOI: 10.1074/Jbc.M507800200  0.44
2005 Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF, Wyllie DJ. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Molecular Pharmacology. 67: 1470-84. PMID 15703381 DOI: 10.1124/Mol.104.008185  0.44
Show low-probability matches.